Zimmer Biomet Holdings, Inc.
ZBH
$97.52
-$0.03-0.03%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.68% | -17.41% | -5.24% | -11.74% | 128.44% |
| Total Depreciation and Amortization | 10.22% | 7.93% | 5.59% | 4.69% | 3.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 456.00% | 3,483.33% | 635.48% | 2,504.76% | -97.73% |
| Change in Net Operating Assets | 51.51% | 44.63% | 25.73% | -14.94% | 4.45% |
| Cash from Operations | 6.61% | 9.16% | 10.14% | -5.20% | 27.81% |
| Capital Expenditure | 0.64% | 22.27% | 32.62% | 26.33% | 18.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -535.04% | -752.28% | -138.19% | -104.82% | -563.53% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 32.22% | 33.22% | -13.66% | -307.04% | -148.41% |
| Cash from Investing | -137.85% | -133.76% | 3.08% | -14.02% | -21.94% |
| Total Debt Issued | 169.08% | 600.17% | 765.59% | 187.37% | 219.95% |
| Total Debt Repaid | -382.54% | -442.46% | -442.46% | -102.16% | 46.70% |
| Issuance of Common Stock | -61.84% | -64.85% | -65.10% | -18.79% | 4.34% |
| Repurchase of Common Stock | 74.36% | -48.49% | -82.87% | -25.40% | -195.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 3.73% | 3.31% | 2.80% | 2.44% | 1.44% |
| Other Financing Activities | -94.82% | -139.93% | -196.80% | -49.04% | -68.35% |
| Cash from Financing | 298.34% | 167.31% | 123.23% | 36.54% | 40.00% |
| Foreign Exchange rate Adjustments | -98.81% | 359.62% | 42.86% | -2,000.00% | 52.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.32% | 36.16% | 1,478.82% | 173.57% | 209.36% |